Director of software development
Amir Emadzadeh holds a PhD in Electrical Engineering from the University of California at Los Angeles (UCLA). Over his 13 years of work experience, he has been granted 10+ patents while at top Silicon Valley companies, including Qualcomm, Nvidia, and Google (Waymo). He is a Director of software in the Digital Transformation Office (DTO) at Genentech (Roche). He is also an adjunct Professor at California Science and Technology University (CSTU). Most recently, he was a Director of data science at Gilead sciences, where he led a team of data scientists and software developers dedicated to improving different aspects of clinical trials. Amir is very passionate about employing AI/ML techniques and automation to tackle pharma/healthcare industry challenges. Some of his recent work includes data-driven feasibility analysis for clinical trials (e.g., clinical trial site/investigator ranking, country assessment, diversity analysis & patient enrollment forecasting), extracting insights from clinical trial documents and sentiment analysis using NLP technology, and medical image segmentation/classification using deep neural networks.